Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Could it be the 4% TFC-1067 data point result
View:
Post by Mickey2 on Mar 01, 2021 10:29am

Could it be the 4% TFC-1067 data point result

from clinical trial news instead?
Comment by pointer on Mar 01, 2021 11:25am
This post has been removed in accordance with Community Policy
Comment by biorun on Mar 01, 2021 11:59am
I remain very open to the possibility that we see something not related to RF and 0.4% this week, before March 9 potential Rodan and Fields market announcement of their next product line or version updates of existing line ups. I have the view that sglt2 clinical trial results and any pets deal as a separate item both remain as areas that can theoretically and realistically be wrapped up and ...more  
Comment by lscfa on Mar 01, 2021 12:52pm
.          Feb 24/21 - Several multinational companies have approached Sirona with interest in TFC-1067. Once the first product is available for purchase and we can release the latest data, we anticipate that number to grow.  
Comment by lscfa on Mar 01, 2021 1:06pm
To be more clear, it sounds like when R+F launches (on March 09?) it will release data from its own trials and this is ahead of 0.4% results which are further away.    Feb 24/21 - Our second clinical trial for TFC-1067, utilizing a higher dose, has been successfully completed and preliminary results have been received from Dermscan. We expect the final report within 4 weeks at ...more